Kayyem Jon Faizinsider trades
In SEC Form 4 filings, Kayyem Jon Faiz is listed as Director of Inhibrx Biosciences, Inc. (INBX). In the last 90 days, Kayyem Jon Faiz bought $1.57M of Inhibrx Biosciences, Inc. (INBX) on the open market and sold none. The largest purchase was $567.6K of Inhibrx Biosciences, Inc. (INBX) on Sep 8. Took part in a cluster buy; the latest at Inhibrx Biosciences, Inc. (INBX), where 2 insiders bought within 13 days, ending Sep 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Director | 4 | Sep 23 |
Cluster buys
- INBX: 2 insiders bought $2.00M between Sep 16 – Sep 28.
Form 4 historysince 2026-09-08
Dashed line = amended filing (Form 4/A)
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Sep 23 | Sep 23 | P | 5,000 | $100.00 | Purchase +$500,000 | 434,360 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Jun 3 | Sep 184/A | A · derivative | 10,000 | $95.22 | $952,200 | 10,000 | No | Form 4/A |
| INBXInhibrx Biosciences, Inc. | Sep 16 | Sep 17 | P | 5,000 | $100.00 | Purchase +$500,000 | 429,360 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 5,000 | $113.52 | Purchase +$567,580 | 424,360 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.